ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19.

Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group.

Open source

DOI
10.1017/cts.2023.644
Published
2023-10-31
Container
J Clin Transl Sci
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1017/cts.2023.644,
  title = {ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19.},
  author = {Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group.},
  year = {2023},
  journal = {J Clin Transl Sci},
  doi = {10.1017/cts.2023.644},
  url = {https://doi.org/10.1017/cts.2023.644}
}

RIS

TY  - JOUR
TI  - ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19.
AU  - Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group.
PY  - 2023
JO  - J Clin Transl Sci
DO  - 10.1017/cts.2023.644
UR  - https://doi.org/10.1017/cts.2023.644
ER  - 

APA

Group., A. C. T. I. A. V. (. S. (2023). ACTIV-6: Operationalizing a decentralized, outpatient randomized platform trial to evaluate efficacy of repurposed medicines for COVID-19.. J Clin Transl Sci. https://doi.org/10.1017/cts.2023.644

Source records